IRCCS Istituto Clinico Humanitas; Oncologia
Rozzano, Lombardia, Italy
Specialized hospital in Italy
Via Alessandro Manzoni, 56, 20089 Rozzano MI
About IRCCS Istituto Clinico Humanitas; Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at IRCCS Istituto Clinico Humanitas; Oncologia
During the past decade, IRCCS Istituto Clinico Humanitas; Oncologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality
2002-04-01
2010-06-01
Completed
4,837
A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer
2010-10-01
2015-07-01
Completed
274
MOCA Versus RFA in the Treatment of Primary Great Saphenous Varicose Veins
2016-12-01
2020-12-31
Completed
213
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
2015-05-01
2023-12-01
Active, not recruiting
4,012
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Istituto Clinico Humanitas; Oncologia"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at IRCCS Istituto Clinico Humanitas; Oncologia
According to Clinical.Site data, the most researched conditions in "IRCCS Istituto Clinico Humanitas; Oncologia" are
"Breast Cancer" (2 trials), "Hematologic Diseases" (2 trials), "Metastatic Colorectal Cancer" (2 trials), "Triple-Negative Breast Cancer" (2 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "IRCCS Istituto Clinico Humanitas; Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at IRCCS Istituto Clinico Humanitas; Oncologia
Most popular intervention types in "IRCCS Istituto Clinico Humanitas; Oncologia" are "Drug" (13 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials), "Placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IRCCS Istituto Clinico Humanitas; Oncologia
The vast majority of trials in "IRCCS Istituto Clinico Humanitas; Oncologia" are
17 trials for "All" genders.
Clinical Trials Status at IRCCS Istituto Clinico Humanitas; Oncologia
Currently, there are NaN active trials in "IRCCS Istituto Clinico Humanitas; Oncologia".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in IRCCS Istituto Clinico Humanitas; Oncologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS Istituto Clinico Humanitas; Oncologia, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".